Cellular Immunity and Herpesvirus Infections in Cardiac-Transplant Patients

New England Journal of Medicine

Volumn 296, Issue 24, 1977, Pages 1372-1377

  Rand, Kenneth H ^a   Rasmussen, Lucille E ^a   Pollard, Richard B ^a   Arvin, Ann ^a   Merigan, Thomas C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRUS ANTIBODY;

CELLULAR IMMUNITY; HEART TRANSPLANTATION; HERPES VIRUS; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE TRANSFORMATION; MAJOR CLINICAL STUDY; THERAPY; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

EID: 0017744152     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197706162962402     Document Type: Article

References (21)

1. Montgomerie JZ, Becroft DMO, Croxson MC, et al: Herpes-simplex-virus infection after renal transplantation. Lancet 2: 867–871, 1969
2. Korsager B, Spencer ES, Mordhorst C-H: Herpesvirus hominis infections in renal transplant recipients. Scand J Infect Dis 7: 11–19, 1975
3. Muller SA, Herrmann EC Jr, Winkelmann RK: Herpes simplex infections in hematologic malignancies. Am J Med 52: 102–114, 1972
4. St. Geme JW, Prince JT, Burke BA, et al: Impaired cellular resistance to herpes-simplex virus in Wiskott-Aldrich syndrome. N Engl J Med 273: 229–234, 1965
5. Rasmussen LE, Jordan GW, Stevens DA, et al: Lymphocyte interferon production and transformation after herpes simplex infections in humans. J Immunol 112: 728–736, 1974
6. Haahr S, Rasmussen L, Merigan TC: Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus. Infect Immun 14: 47–54, 1976
7. Schober R, Herman MM: Neuropathology of cardiac transplantation: survey of 31 cases. Lancet 1: 962–967, 1973
8. Stinson EB, Bieber CP, Griepp RB, et al: Infectious complications after cardiac transplantation in man. Ann Intern Med 74: 22–36, 1971
9. Schmidt NJ, Lennette EH, Schor CW: A complement-fixing antigen for herpes simplex derived from chick-embryo tissue cultures. Am J Hyg 72: 59–72, 1960
10. Douglas RG Jr, Couch RB: A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol 104: 289–295, 1970
11. Ruffault A, Fauconnier B. Précocité de l' isolement du virus herpétique dans la salive de malades immunodéprimés, antérieurement infectés. Pathol Biol 24: 37–39, 1976
12. Park RK, Goltz RW, Carey TB: Unusual cutaneous infections associated with immunosuppressive therapy. Arch Dermatol 95: 345–350, 1967
13. Khalaf TH, Strober S, Garrelts G, et al: Alterations in T and B lymphocytes in heart transplant patients early and late postoperatively. J Clin Invest 58: 212–220, 1976
14. Rytel MW, Balay J: Impaired production of interferon in lymphocytes from immunosuppressed patients. J Infect Dis 127: 445–449, 1973
15. Rager-Zisman B, Bloom BR: Immunological destruction of herpes simplex virus I infected cells. Nature 251: 542–543, 1974
16. Babiuk LA, Wardley RC, Rouse BT: Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect Immun 12: 958–963, 1975
17. Shore SL, Black CM, Melewicz FM, et al: Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol 116: 194–201, 1976
18. Mitus A, Holloway A, Evans AE, et al: Attenuated measles vaccine in children with acute leukemia. Am J Dis Child 103: 413–418, 1962
19. Mihatsch MJ, Ohnacker H, Just M, et al: Lethal measles giant cell pneumonia after live measles vaccination in a case of thymic alymphoplasia (Gitlin). Helv Paediatr Acta 27: 143–146, 1975
20. Duff R, Rapp F: Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature [New Biol] 233: 48–50, 1971
21. Hope-Simpson RE: The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58: 9–20, 1965